NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 918 filers reported holding NOVARTIS A G in Q3 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $209,760 | +1.4% | 2,280 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $206,842 | +1.9% | 2,280 | -1.3% | 0.00% | 0.0% |
Q1 2022 | $203,000 | -8.6% | 2,309 | -9.0% | 0.00% | 0.0% |
Q4 2021 | $222,000 | -3.9% | 2,536 | +0.2% | 0.00% | 0.0% |
Q2 2021 | $231,000 | +6.9% | 2,530 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $216,000 | -15.3% | 2,530 | -6.3% | 0.00% | -33.3% |
Q4 2020 | $255,000 | +3.7% | 2,700 | -4.6% | 0.00% | 0.0% |
Q3 2020 | $246,000 | -7.2% | 2,830 | -6.6% | 0.00% | 0.0% |
Q2 2020 | $265,000 | +6.0% | 3,030 | 0.0% | 0.00% | -25.0% |
Q1 2020 | $250,000 | -9.1% | 3,030 | +4.5% | 0.00% | +33.3% |
Q4 2019 | $275,000 | +9.1% | 2,900 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $252,000 | -4.9% | 2,900 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $265,000 | -5.0% | 2,900 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $279,000 | +12.0% | 2,900 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $249,000 | -9.8% | 2,900 | -9.4% | 0.00% | 0.0% |
Q3 2018 | $276,000 | +14.0% | 3,200 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $242,000 | -8.0% | 3,200 | -1.5% | 0.00% | 0.0% |
Q1 2018 | $263,000 | -16.5% | 3,250 | -13.3% | 0.00% | -25.0% |
Q4 2017 | $315,000 | -2.2% | 3,750 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $322,000 | -9.3% | 3,750 | -11.8% | 0.00% | 0.0% |
Q2 2017 | $355,000 | -18.9% | 4,250 | -27.9% | 0.00% | -20.0% |
Q1 2017 | $438,000 | -0.7% | 5,894 | -2.6% | 0.01% | -16.7% |
Q4 2016 | $441,000 | -12.2% | 6,053 | -4.7% | 0.01% | -14.3% |
Q3 2016 | $502,000 | +60.9% | 6,354 | +68.1% | 0.01% | +75.0% |
Q2 2016 | $312,000 | +13.9% | 3,780 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $274,000 | -21.9% | 3,780 | -7.4% | 0.00% | -20.0% |
Q4 2015 | $351,000 | -6.4% | 4,080 | 0.0% | 0.01% | -16.7% |
Q3 2015 | $375,000 | -6.5% | 4,080 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $401,000 | -0.2% | 4,080 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $402,000 | +1.3% | 4,080 | -4.7% | 0.01% | 0.0% |
Q4 2014 | $397,000 | -2.7% | 4,280 | -1.2% | 0.01% | 0.0% |
Q3 2014 | $408,000 | +9.7% | 4,331 | +5.5% | 0.01% | +20.0% |
Q2 2014 | $372,000 | +6.6% | 4,105 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $349,000 | +22.0% | 4,105 | +15.5% | 0.01% | +25.0% |
Q4 2013 | $286,000 | -2.4% | 3,555 | -7.0% | 0.00% | -20.0% |
Q3 2013 | $293,000 | -3.6% | 3,824 | -10.9% | 0.01% | -16.7% |
Q2 2013 | $304,000 | – | 4,293 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |